Dispatches from SupplySide West 2013
UNPA chief agrees with FDA that GMP compliance far from uniform
Adverse event reporting, amphetamine-like substances showing up in products and NDI notifications are all prominent blips on FDA’s radar, said Loren Israelsen, president of the United Natural Products Alliance.